Abstract

Hydrocortisone 2% in Versapro Cream

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2023 - Volume 27, Number 5

Page(s): 416

Download in electronic PDF format for $75
  • Hydrocortisone 2% in Versapro Cream Page 1

Abstract

A formulation for preparing Hydrocortisone 2% in Versapro Cream. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • hydrocortisone
  • formulation
  • topical preparation
  • corticosteroid
  • inflammation
  • inflammatory eye diseases
  • inflammatory ear diseases

Related Categories

  • DERMATOLOGY
  • EAR NOSE THROAT
  • FORMULATIONS
  • OPHTHALMICS
  • ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2023
Pg. 416
Hydrocortisone 2% in Versapro Cream
Author(s): Allen Loyd V Jr
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Jul/Aug 2020
Pg. 315
Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Sep/Oct 2023
Pg. 422-423
Silver Sulfadiazine 1% and Hydrocortisone 2% Gel
Author(s): Allen Loyd V Jr
May/Jun 2003
Pg. 188-191
Treating Canine Hepatic Disease
Author(s): Davidson Gigi S
Jul/Aug 2022
Pg. 293-296
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Author(s): Harrington Amy, Williams LaVonn
Nov/Dec 2023
Pg. 492
Hydrocortisone 2% and Menthol 0.5% in VersaPro Cream Base
Author(s): Allen Loyd V Jr
Sep/Oct 2013
Pg. 380-383
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
Author(s): McElhiney Linda F
Mar/Apr 2004
Pg. 101-105
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
Sep/Oct 2007
Pg. 423
Hydrocortisone 0.5% Ethanolic Gel
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 57
Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment
Author(s): Allen Loyd V Jr
Mar/Apr 2016
Pg. 155-158
Utilization of Compounded Medications in an Oral Medicine Practice
Author(s): Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
Sep/Oct 2015
Pg. 357-365
Novel Approaches to Topical Psoriasis Therapy
Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Jan/Feb 2018
Pg. 66-75
Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension
Author(s): Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H
Jul/Aug 2008
Pg. 295-304
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
Sep/Oct 2014
Pg. 418-426
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation
Author(s): Robert Marie-Claude, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H
Jan/Feb 2011
Pg. 65
Hydrocortisone Acetate 1% Gel, Alcohol-Free
Author(s): Allen Loyd V Jr
Jul/Aug 2011
Pg. 302-307
Treating Inner Ear Disorders with Intratympanic Drug Administration
Author(s): McElhiney Linda F
May/Jun 2008
Pg. 265
Miconazole Nitrate 2%, Deoxy-D-Glucose 0.2%, and Hydrocortisone 0.4% Lip Balm
Author(s): Allen Loyd V Jr